A recent study revealed that MICAL-L2 contributes to Wnt/β-catenin signaling activation in ovarian cancer cells and that the silencing of MICAL-L2 abrogates the nuclear translocation of β-catenin and induces EMT [22]. This evidence concerns the gene MICALL2 and ovarian cancer.